Exact Sciences Exact Sciences shares plunged Wednesday after the company reported widening losses. The maker of the Cologuard colon cancer screening test lowered its full-year outlook.

At this time, I would like to welcome everyone to the Exact Sciences. Third quarter ... 1.2 million patients including a record number with Cologuard and Etty DX. Growing total revenue 13% ...

Exact Sciences Corp. is a prominent company in the healthcare sector specializing in cancer screening and diagnostic tests, known for its innovative solutions such as the Cologuard and Oncotype DX ...

Exact Sciences Corporation EXAS reported a net ... Screening revenues, including laboratory service revenues from Cologuard and PreventionGenetics, totaled $544.9 million. The figure increased ...

At this time, I would like to welcome everyone to the Exact Sciences Third Quarter 2024 ... including a record number with Cologuard and Oncotype DX, growing total revenue 13% year-over-year ...

Exact Sciences' Q3 earnings report ... the launch of Cologuard Plus, which it seems will be priced higher than the existing test kit. Private insurers and the Centers for Medicaid and Medicare ...

Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue ...

Modeling data show Cologuard PlusTM test delivers highest life-years gained with fewest number of colonoscopies among noninvasive colorectal cancer (CRC) screening strategies “Exact Sciences is ...

Exact Sciences Corporation (NASDAQ:EXAS), a leader in cancer screening and diagnostic tests, has recently filed its 10-Q report on November 5, 2024. The company, known for its noninvasive Cologuard ...

Exact Sciences will also present new data on improving adherence to help close the gap in CRC screening. ACG abstracts are available on the meeting website. “Exact Sciences is pleased to share new ...

“Exact Sciences is pleased to share new modeling data which demonstrates the Cologuard Plus test as an ... with an average of 25.5 days to return the kit; This supports mt-sDNA as an effective ...